Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

8.50
Delayed Data
As of Jan 19
 -0.62 / -6.80%
Today’s Change
5.21
Today|||52-Week Range
16.30
+18.72%
Year-to-Date
No recent news for Advaxis Inc.

Today’s Trading

Previous close9.12
Today’s open9.29
Day’s range8.50 - 9.40
Volume754,020
Average volume (3 months)766,583
Market cap$366.1M
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-23.81%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales71.69
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-0.19-1.14%
NOVNNovan Inc-0.81-3.48%
SPPISpectrum Pharmaceuti...-0.01-0.22%
TLGTTeligent Inc-0.15-2.21%
Data as of 4:00pm ET, 01/19/2017

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$4.0M
Annual profit (last year)-$73.6M
Net profit margin-1,841.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
Chief Operating Officer &
Senior Vice President
Christopher M. Duke
Corporate headquarters
Princeton, New Jersey

Forecasts


Search for Jobs